Results 141 to 150 of about 4,325,962 (256)

Piclidenoson, an A3 adenosine receptor agonist, demonstrates clinical benefit in canine osteoarthritis: a pilot study. [PDF]

open access: yesFront Vet Sci
Hanf R   +12 more
europepmc   +1 more source

Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy

open access: yes, 2019
Shira Cohen, Pnina FishmanCan-Fite BioPharma Ltd., Kiryat-Matalon, Petah-Tikva 49170, IsraelAbstract: Cancer patients undergoing immunotherapy may develop cytokine release syndrome (CRS), an inflammatory cytokine storm condition, followed by neurotoxic ...
Fishman P, Cohen S
core  

Atomistic insights into the magnetic-field modulation of the [Formula: see text] adenosine receptor. [PDF]

open access: yesSci Rep
Pisano C   +9 more
europepmc   +1 more source

Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor

open access: yesMolecular Pharmacology, 2015
G. Lebon   +3 more
semanticscholar   +1 more source

Adenosine; adenosine A2b receptor [PDF]

open access: yesScience-Business eXchange, 2008
openaire   +1 more source

Caffeine-mediated CD39<sup>+</sup> Treg activation via the CD39-adenosine receptor pathway is a novel risk factor for pulmonary tuberculosis. [PDF]

open access: yesFront Immunol
Zhu L   +17 more
europepmc   +1 more source

Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice

open access: yesScience Translational Medicine, 2013
Carla G. Silva   +18 more
semanticscholar   +1 more source

Caffeine-associated reduction in patent ductus arteriosus is mediated in part by adenosine receptor antagonism. [PDF]

open access: yesAm J Physiol Heart Circ Physiol
Crockett SL   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy